Abstract
This study aimed to examine effects of adjunctive baicalin therapy to ampicillin for experimental bacterial meningitis in rabbits. After Escherichia Coli inoculation, mean leukocyte counts, concentrations of protein, tumor necrosis factor-α (TNF-α), interleukin-1 (IL-1) and lactate in cerebrospinal fluid (CSF), brain water content and mean arterial and intracranial pressures substantially increased in the meningitis group. Ampicillin alone for 5 h markedly exacerbated the enhanced leukocyte counts and protein concentration, and showed no significant effect on the elevated CSF TNF-α, IL-1 and lactate concentration, mean arterial and intracranial pressures, and brain water content. Baicalin (7-D-glucuronic acid-5,6-dihydroxyflavone, C21H18O11) completely counteracted ampicillin-induced exacerbation, and further alleviated the enhanced mean leukocyte counts and protein concentration when combined with ampicillin. Adjunctive baicalin also significantly ameliorated the elevated CSF TNF-α, IL-1 and lactate concentration, mean arterial and intracranial pressures, and brain water content. Baicillin, as an adjunctive treatment exerted multiple therapeutic effects in experimental bacterial meningitis.
Similar content being viewed by others
References
Singhi, P., A. Bansal, P. Geeta, and S. Singhi. 2007. Predictors of long term neurological outcome in bacterial meningitis. Indian J Pediatr. 74(4): 369–374.
Lucas, S.M., N.J. Rothwell, and R.M. Gibson. 2006. The role of inflammation in CNS injury and disease. Br. J. Pharmacol. 147: S232–S240.
Mace, S.E. 2008. Acute bacterial meningitis. Emerg. Med. Clin. North Am. 26: 281–317.
Yogev, R., and J. Guzman-Cottrill. 2005. Bacterial meningitis in children: critical review of current concepts. Drugs 65: 1097–1112.
Chaudhuri, A. 2004. Adjunctive dexamethasone treatment in acute bacterial meningitis. Lancet Neurol. 3: 54–62.
Spreer, A., J. Gerber, M. Hanssen, S. Schindler, C. Hermann, P. Lange, H. Eiffert, and R. Nau. 2006. Dexamethasone increases hippocampal neuronal apoptosis in a rabbit model of Escherichia coli meningitis. Pediatr. Res. 60: 210–215.
Li-Weber, M. 2009. New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin. Cancer Treat Rev. 35: 57–68.
Kubo, M., Y. Kimura, T. Odani, T. Tani, and K. Namba. 1981. Studies on Scutellariae radix. Part II: The antibacterial substance. Planta Med. 43: 194–201.
Ng, T.B., J.M. Ling, Z.T. Wang, J.N. Cai, and G.J. Xu. 1996. Examination of coumarins, flavonoids and polysaccharopeptide for antibacterial activity. Gen. Pharmacol. 27: 1237–1240.
Yang, Y.J., C.Y. Zhu, X. Chen, R. Huang, and X.Z. Li. 1998. The protective effects of baicalin on pertussis bacilli-induced brain edema in rats. Natl. Med. J. China 78: 630–632.
Gao, Z., K. Huang, X. Yang, and H. Xu. 1999. Free radical scavenging and antioxidant activities of flavonoids extracted from the radix of Scutellaria baicalensis Georgi. Biochem. Biophys. Acta. 1472: 643–650.
Li, B.Q., T. Fu, W.H. Gong, N. Dunlop, H. Kung, Y. Yan, J. Kang, and J.M. Wang. 2000. The flavonoid baicalin exhibits anti-inflammatory activity by binding to chemokines. Immunopharmacology 49: 295–306.
Chou, T.C., L.P. Chang, C.Y. Li, C.S. Wong, and S.P. Yang. 2003. The Antiinflammatory and analgesic effects of baicalin in carrageenan-evoked thermal hyperalgesia. Anesth. Analg. 97: 1724–1729.
Lee, H.H., L.L. Yang, C.C. Wang, S.Y. Hu, S.F. Chang, and Y.H. Lee. 2003. Differential effects of natural polyphenols on neuronal survival in primary cultured central neurons against glutamate- and glucose deprivation-induced neuronal death. Brain Res. 986: 103–113.
Li, T.F., Y.M. Luo, and C.Z. Lu. 2003. Effect of baicalin on neuronal apoptosis induced by limbic seizure following kainic acid injection into a mygdaloid nucleu. Chin. J. Neurosc. 19: 395–400.
Huang, Y., S.Y. Tsang, X. Yao, and Z.Y. Chen. 2005. Biological properties of baicalein in cardiovascular system. Curr. Drug Targets Cardiovasc. Haematol. Disord. 5: 177–184.
Ge, Q.F., X. Hu, Z.Q. Ma, J.R. Liu, W.P. Zhang, Z. Chen, and E.Q. Wei. 2007. Baicalin attenuates oxygen-glucose deprivation-induced injury via inhibiting NMDA receptor-mediated 5-lipoxygenase activation in rat cortical neurons. Pharmacol. Res. 55: 148–157.
Wang, C.Z., S.R. Mehendale, and C.S. Yuan. 2007. Commonly used antioxidant botanicals: active constituents and their potential role in cardiovascular illness. Am. J. Chin. Med. 35: 543–558.
Liu, Y.X. 1993. Effects of anisodamine and ampicillin on cerebrospinal fluid in experimental E. coli meningitis. Zhonghua Yi Xue Za Zhi 73: 289–291.
Yue, S., Q. Li, S. Liu, Z. Luo, F. Tang, D. Feng, and P. Yu. 2006. Mechanism of neuroprotective e¤ect induced by QingKaiLing as an adjuvant drug in rabbits with E. coli bacterial meningitis. Acta Neurochir 96: 413–418.
Tsai, C.C., M.T. Lin, J.J. Wang, J.F. Liao, and W.T. Huang. 2006. The antipyretic effects of baicalin in lipopolysaccharide-evoked fever in rabbits. Neuropharmacology 51(4): 709–717.
Aronin, S.I. 2000. Bacterial Meningitis: Principles and Practical Aspects of Therapy. Curr. Infect. Dis. Rep. 2: 337–344.
van der Flier, M., S.P. Geelen, J.L. Kimpen, I.M. Hoepelman, and E.I. Tuomanen. 2003. Reprogramming the host response in bacterial meningitis: how best to improve outcome? Clin. Microbiol. Rev. 16: 415–429.
Schultzberg, M., C. Lindberg, A.F. Aronsson, E. Hjorth, S.D. Spulber, and M. Oprica. 2007. Inflammation in the nervous system—physiological and pathophysiological aspects. Physiol. Behav. 92: 121–128.
Nau, R., and W. Brück. 2002. Neuronal injury in bacterial meningitis: mechanisms and implications for therapy. Trends Neurosci. 25: 38–45.
Bashir, H.El, M. Laundy, and R. Booy. 2003. Diagnosis and treatment of bacterial meningitis. Arch. Dis. Child 88: 615–620.
Leib, S.L., and M.G. Täuber. 1999. Pathogenesis of bacterial meningitis. Infect Dis Clin. North Am. 13: 527–548.
Gladden, L.B. 2004. Lactate metabolism: a new paradigm for the third millennium. J Physiol. 558: 5–30.
Mustafa, M.M., M.H. Lebel, O. Ramilo, K.D. Olsen, J.S. Reisch, B. Beutler, and G.H. McCracken Jr. 1989. Correlation of interleukin- 1,6 and cachectin concentrations in cerebrospinal fluid and outcome from bacterial meningitis. J. Pediatr 115: 208–213.
Koedel, U., W.M. Scheld, and H.W. Pfister. 2002. Pathogenesis and pathophysiology of pneumococcal meningitis. Lancet Infect. Dis. 2: 721–736.
McIntyre, P.B., C.S. Berkey, S.M. King, U.B. Schaad, T. Kilpi, G.Y. Kanra, and C.M. Perez. 1997. Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988. J. Am. Med. Assoc 278: 925–931.
Zysk, G. 1996. Anti-inflammatory treatment influences neuronal apoptotic. Neuropathol. Exp. Neurol. 55: 722–728.
Leib, S.L., C. Heimgartner, Y.D. Bifrare, J.M. Loeffler, and M.G. Täauber. 2003. Dexamethasone aggravates hippocampal apoptosis and learning deficiency in pneumococcal meningitis in infant rats. Pediatr. Res. 54: 353–357.
Kim, H.K., B.S. Cheon, Y.H. Kim, S.Y. Kim, and H.P. Kim. 1999. Effects of naturally occurring flavonoids on nitric oxide production in the macrophage cell line RAW 264. 7 and their structure-activity relationships. Biochem. Pharmacol. 58: 759–765.
Chen, Y.C., S.C. Shen, L.G. Chen, T.J. Lee, and L.L. Yang. 2001. Wogonin, Baicalin and Baicalein inhibition of inducible nitric oxide synthase and cyclooxygenase-2 gene expressions induced by nitric oxide synthase inhibitors and lipopolysaccharide. Biochem. Pharmacol. 61: 1417–1427.
Krakauer, T., B.Q. Li, and H.A. Young. 2001. The flavonoid baicalin inhibits superantigen-induced inflammatory cytokines and chemokines. FEBS Letters 500: 52–55.
Park, B.K., M.Y. Heo, H. Park, and H.P. Kim. 2001. Inhibition of TPA-induced cyclooxygenase-2 expression and skin inflammation in mice by Wogonin, a plant flavone from Scutellaria radix. Eur. J. Pharmacol. 425: 153–157.
Huang, Y., C.M. Wong, C.W. Lau, X. Yao, S.Y. Tsang, Y.L. Su, and Z.Y. Chen. 2004. Inhibition of nitric oxide/cyclic GMP-mediated relaxation by purified flavonoids, baicalin and baicalein, in rat aortic rings. Biochem. Pharmacol. 67: 787–794.
Woo, K.J., J.H. Lim, S.I. Suh, Y.K. Kwon, S.W. Shin, S.C. Kim, Y.H. Choi, J.W. Park, and T.K. Kwon. 2006. Differential inhibitory effects of baicalein and baicalin on LPS-induced cyclooxygenase-2 expression through inhibition of C/EBPbeta DNA-binding activity. Immunobiology 211: 359–368.
Allan, S.M., P.J. Tyrrell, and N.J. Rothwell. 2005. Interleukin-1 and neuronal injury. Nat. Rev. Immunol. 5: 629–640.
Rangel-Castilla, L., S. Gopinath, and C.S. Robertson. 2008. Management of Intracranial Hypertension. Neurol. Clin. 26: 521–541.
Dziedzic, T., A. Szczudlik, A. Klimkowicz, T.M. Rog, and A. Slowik. 2003. Is mannitol safe for patients with intracerebral hemorrhages? Renal considerations. Clin. Neurol. Neurosurg. 105: 87–89.
Mirski, A.M., I.D. Denchev, S.M. Schnitzer, and F.D. Hanley. 2000. Comparison between hypertonic saline and mannitol in the reduction of elevated intracranial pressure in a rodent model of acute cerebral injury. J. Neurosurg. Anesthesiol. 12: 334–344.
Cushnie, T.P., V.E. Hamilton, and A.J. Lamb. 2003. Assessment of the antibacterial activity of selected flavonoids and consideration of discrepancies between previous reports. Microbiol. Res. 158: 281–289.
Liu, I.X., D.G. Durham, and R.M. Richards. 2000. Baicalin synergy with beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus and other beta-lactam-resistant strains of S. aureus. J. Pharm. Pharmacol. 52: 361–366.
Acknowledgements
This work was supported by grants from the National Natural Science Foundation of China (39700193) and by the Hunan Traditional Medicine and Drug Research Foundation (204048 and 2009054)
Author information
Authors and Affiliations
Corresponding author
Additional information
Fu-Wen Zhou contributed equally as first authors.
Rights and permissions
About this article
Cite this article
Tang, YJ., Zhou, FW., Luo, ZQ. et al. Multiple Therapeutic Effects of Adjunctive Baicalin Therapy in Experimental Bacterial Meningitis. Inflammation 33, 180–188 (2010). https://doi.org/10.1007/s10753-009-9172-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-009-9172-9